Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Mohammed A. Farooqui"'
Autor:
Tristan B. Raisch, Matthew S. Yanoff, Timothy R. Larsen, Mohammed A. Farooqui, D. Ryan King, Rengasayee Veeraraghavan, Robert G. Gourdie, Joseph W. Baker, William S. Arnold, Soufian T. AlMahameed, Steven Poelzing
Publikováno v:
Frontiers in Physiology, Vol 9 (2018)
Aims: Atrial fibrillation (AF) is the most common sustained arrhythmia. Previous evidence in animal models suggests that the gap junction (GJ) adjacent nanodomain – perinexus – is a site capable of independent intercellular communication via epha
Externí odkaz:
https://doaj.org/article/7ab7683ae54b4471a4b56b3581a82186
Publikováno v:
University of Sharjah Journal of Law Sciences (JLS); 2024, Vol. 21 Issue 1, p550-568, 19p
Autor:
Kevin H. Lin, Lynn Huynh, Xiaoqin Yang, Neema Lema, Lisa Matay, Sobana Balasubramanian, Daria Liborski, Mikaela M. McDonough, Jillian Foreman, Mohammed Z.H. Farooqui, Enrico De Nigris, Shravanthi R. Gandra, Eric Sarpong, Mei Sheng Duh, Jennifer R. Brown, Matthew S. Davids
Publikováno v:
Blood. 140:4150-4152
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d69ae57b8a7007ca112a2154adf34c20
https://doi.org/10.1182/blood-2022-160389
https://doi.org/10.1182/blood-2022-160389
Publikováno v:
Journal of the Royal College of Physicians of Edinburgh. 52:142-146
Pneumonia is one of the illnesses for which pulmonary embolism (PE) is most often mistaken because of the considerable overlap in their clinical picture. Moreover, pneumonia may occasionally mask PE, particularly in patients with predominant systemic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1d3f57b6f633ceba6f59f1f0d3ff761
https://doi.org/10.1177/14782715221103670
https://doi.org/10.1177/14782715221103670
Autor:
Adrian Wiestner, Sarah E.M. Herman, Mohammed Z.H. Farooqui, Susan Soto, Janet Valdez, Constance Yuan, Katherine R. Calvo, Gerald E. Marti, Maryalice Stetler-Stevenson, Dalia Salem, Irina Maric, Sabrina Martyr, Yuh Shan Lee, Carsten U. Niemann, Martin Skarzynski
Supplementary Table 1. Characteristics of all patients studied.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cdd70a438548a7b009c9e3c32f69a81
https://doi.org/10.1158/1078-0432.22460525.v1
https://doi.org/10.1158/1078-0432.22460525.v1
Autor:
Adrian Wiestner, Sarah E.M. Herman, Mohammed Z.H. Farooqui, Susan Soto, Janet Valdez, Constance Yuan, Katherine R. Calvo, Gerald E. Marti, Maryalice Stetler-Stevenson, Dalia Salem, Irina Maric, Sabrina Martyr, Yuh Shan Lee, Carsten U. Niemann, Martin Skarzynski
Purpose: Clinical trials of ibrutinib combined with anti-CD20 monoclonal antibodies (mAb) for chronic lymphocytic leukemia (CLL) report encouraging results. Paradoxically, in preclinical studies, in vitro ibrutinib was reported to decrease CD20 expre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a41928f3f6f4ebd931aba859a7633a0b
https://doi.org/10.1158/1078-0432.c.6524525
https://doi.org/10.1158/1078-0432.c.6524525
Autor:
Adrian Wiestner, Sarah E.M. Herman, Mohammed Z.H. Farooqui, Susan Soto, Janet Valdez, Constance Yuan, Katherine R. Calvo, Gerald E. Marti, Maryalice Stetler-Stevenson, Dalia Salem, Irina Maric, Sabrina Martyr, Yuh Shan Lee, Carsten U. Niemann, Martin Skarzynski
Supplementary Figure 1. Uniform CD20 loss from the surface of primary CLL cells after in vivo exposure to ibrutinib. Supplementary Figure 2. Loss of CD20 on ibrutinib and basal CD20 expression levels do not correlate with high risk prognostic factors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2332dc015698f9359a07227a64e00f6
https://doi.org/10.1158/1078-0432.22460528.v1
https://doi.org/10.1158/1078-0432.22460528.v1
Autor:
Adrian Wiestner, Mohammed Z.H. Farooqui, Gerald E. Marti, Clare Sun, Jade Jones, Deanna H. Wong, Yuh Shan Lee, Janet Valdez, Raul C. Braylan, Katherine R. Calvo, Constance M. Yuan, Maryalice Stetler-Stevenson, Sabrina Martyr, Betty Y. Chang, Angelique Biancotto, Julio Gomez-Rodriguez, Irina Maric, Sarah E.M. Herman, Carsten U. Niemann
Supplementary Figure S1. Ibrutinib alters the absolute expression of inflammatory cytokines and chemokines in serum from patients with CLL. Supplementary Figure S2. Ibrutinib treatment reduces tumor burden. Supplementary Figure S3. Both CD4+ and CD8+
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32e50ac17a3a9bb641231f5544d0d364
https://doi.org/10.1158/1078-0432.22459319.v1
https://doi.org/10.1158/1078-0432.22459319.v1
Autor:
Adrian Wiestner, Mohammed Z.H. Farooqui, Gerald E. Marti, Clare Sun, Jade Jones, Deanna H. Wong, Yuh Shan Lee, Janet Valdez, Raul C. Braylan, Katherine R. Calvo, Constance M. Yuan, Maryalice Stetler-Stevenson, Sabrina Martyr, Betty Y. Chang, Angelique Biancotto, Julio Gomez-Rodriguez, Irina Maric, Sarah E.M. Herman, Carsten U. Niemann
Purpose: Chronic lymphocytic leukemia (CLL) cells depend on microenvironmental interactions for proliferation and survival that are at least partially mediated through B-cell receptor (BCR) signaling. Ibrutinib, a Bruton tyrosine kinase inhibitor, di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee0ee2a10c4636dcb0bdb40a74d5e528
https://doi.org/10.1158/1078-0432.c.6524195.v1
https://doi.org/10.1158/1078-0432.c.6524195.v1
Autor:
Adrian Wiestner, Mohammed Z.H. Farooqui, Gerald E. Marti, Clare Sun, Jade Jones, Deanna H. Wong, Yuh Shan Lee, Janet Valdez, Raul C. Braylan, Katherine R. Calvo, Constance M. Yuan, Maryalice Stetler-Stevenson, Sabrina Martyr, Betty Y. Chang, Angelique Biancotto, Julio Gomez-Rodriguez, Irina Maric, Sarah E.M. Herman, Carsten U. Niemann
Supplementary Table S1: Evaluation of serum cytokine levels on ibrutinib Supplementary Table S2: Evaluation of chemoattractant levels in bone marrow supernatant on ibrutinib supplementary figure legends for supplementary figures S1-S5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37a4e0e6190872466661951229717364
https://doi.org/10.1158/1078-0432.22459316
https://doi.org/10.1158/1078-0432.22459316